SPRYCEL
- Dasatinib - @- Protein Tyrosine Kinase Inhibitors - Antineoplastic Agents- (Aug 2006)
Compositions:
Dasatinib 20mg/50mg/70mg tablets,
List of Related Indications:
Dasatinib 20mg/50mg/70mg tablets,
- Chronic lymphocytic leukemia -CLL
| Strength | Rate | Packing Style |
|---|---|---|
| 20mg | 82820.00 | 60s tablets |
| 50mg | 197238.00 | 60s tablets |
| 70mg | 190585.00 | 60s tablets |
Manufacturer Details